The DOI matches its Crossref record; 159 of the 160 references it cites were found in a registry or an index.
Delivery of Therapeutic Proteins
Open accessAbstract
The safety and efficacy of protein therapeutics are limited by three interrelated pharmaceutical issues, in vitro and in vivo instability, immunogenicity and shorter half-lives. Novel drug modifications for overcoming these issues are under investigation and include covalent attachment of poly(ethylene glycol) (PEG), polysialic acid, or glycolic acid, as well as developing new formulations containing nanoparticulate or colloidal systems (e.g., liposomes, polymeric microspheres, polymeric nanoparticles). Such strategies have the potential to develop as next generation protein therapeutics. This review includes a general discussion on these delivery approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PEGylation is widely used in such modification for the delivery of proteins/peptides into the human body.35”
From Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor (2019) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,312
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,951
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., & Kasper, D. L. (2005) · Cell · doi:10.1016/j.cell.2005.05.007 · Cited by 2,910
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,344
Chemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00022-4 · Cited by 1,628
Abuchowski, A., Es, T. V., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
Flagged first, then by citations
1 of the 160 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Kinstler, 1999, N-terminally chemically modified protein compositions and methods, United States Patent 5985265
- Mundargi, 2008, Nano/micro technologies for delivering macro- molecular therapeutics using poly(d, l-lactide-co-glycolide) and its derivatives, J Control Release, 125, 193, 10.1016/j.jconrel.2007.09.013 · DOI · Paper page
Cited by
Sorted by citations
Items 401–500 of 534
Krobthong, S., Yingchutrakul, Y., Wongtrakoongate, P., Chuntakaruk, H., Rungrotmongkol, T., Chaichana, C., Mahatnirunkul, T., Chomtong, T., Choowongkomon, K., & Aonbangkhen, C. (2023) · Foods · doi:10.3390/foods12040780 · Cited by 6
Das, B. K., Gao, J., & Bandyopadhyay, A. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216960 · Cited by 6
Block copolymer micelles as long-circulating drug delivery vehicles
Abuwatfa, W. H., AlSawaftah, N., & Husseini, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89868-3.00023-9 · Cited by 5
Bansal, A., Zhang, J., Lu, Q., Mei, Q., & Zhang, Y. (2023) · Biomaterials Science · doi:10.1039/d2bm01890j · Cited by 5
Matrixed CDR grafting: A neoclassical framework for antibody humanization and developability
Gupta, P., Horspool, A. M., Trivedi, G., Moretti, G., Datar, A., Huang, Z.-F., Chiecko, J., Kenny, C. H., & Marlow, M. S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105555 · Cited by 6
“Lost sugars” — reality of their biological and medical applications
Talafová, K., & Nahálka, J. (2012) · Open Life Sciences · doi:10.2478/s11535-012-0079-3 · Cited by 4
Nagasawa, K., Meguro, M., Sato, K., Tanizaki, Y., Nogawa-Kosaka, N., & Kato, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124676 · Cited by 5
Transfection of Heat Shock Protein 70 kDa (HSP70)
Gestin, M., Falato, L., Ciccarelli, M., Cerrato, C. P., Andréasson, C., & Langel, Ü. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-022-10416-y · Cited by 5
Advantages of nanodrug targeting than conventional dosage system
Ulucan‐Karnak, F., & Kuru, C. İ. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95325-2.00003-1 · Cited by 5
Sakai‐Kato, K., Nanjo, K., & Goda, Y. (2018) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c18-00279 · Cited by 5
The Delivery of Drugs – Peptides and Proteins
Schiffter, H. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-444-64046-8.00309-8 · Cited by 5
PEPTIDE DELIVERY VIA NASAL ROUTE: EXPLORING RECENT DEVELOPMENTS AND APPROACHES
PALDE, C., Barot, T., Chakraborthy, G. S., & PATEL, L. D. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024v16i4.50626 · Cited by 4
Sediq, A. S., Waasdorp, S. K. D., Nejadnik, M. R., van Beers, M. M. C., Meulenaar, J., Verrijk, R., & Jiskoot, W. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.07.015 · Cited by 4
Zhang, Y., Ma, Q., Wang, J., Ge, J., Hua, J., Shi, Y., Zhang, C., Liu, M., Wang, Y., Chen, Z., et al. (2019) · The Protein Journal · doi:10.1007/s10930-019-09836-5 · Cited by 4
Silva, A. L. D. F. E., Elcoroaristizabal, S., & Ryder, A. G. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27483 · Cited by 4
Malviya, R., Verma, S., & Sundram, S. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666211118111506 · Cited by 4
LeValley, P. J., Parsons, A. L., Sutherland, B. P., Kiick, K. L., Oakey, J. S., & Kloxin, A. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051062 · Cited by 4
Plant polysaccharides for orthopedic drug delivery
Hormozi, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90780-4.00006-1 · Cited by 4
Strategies for Formulation and Systemic Delivery of Therapeutic Proteins
Shah, P., & Basant (2023) · Springer eBooks · doi:10.1007/978-981-19-8249-1_6 · Cited by 4
Amino acid-mPEGs: Promising excipients to stabilize human growth hormone against aggregation.
Vakili, S., Chamani, J., Amiri‐Tehranizadeh, Z., Hosseinzadeh, H., Mosaffa, F., Khatami, S., Khameneh, B., & Saberi, M. R. (2023) · PubMed Central · doi:10.22038/ijbms.2023.67557.14804 · Cited by 4
Modulation of protein release from penta-block copolymer microspheres
Le, M.-Q., Gimel, J.-C., Garric, X., Nguyen-Pham, T.-Q., Paniagua, C., Riou, J., & Venier‐Julienne, M. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.05.009 · Cited by 4
Evaluation of biodegradable polyester-co-lactone microparticles for protein delivery
Tawfeek, H. M., Khidr, S. H., Samy, E. M., Ahmed, S. M., Gaskell, E. E., & Hutcheon, G. A. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.814060 · Cited by 4
The Protein/Peptide Direct Virus Inactivation During Chromatographic Process: Developing Approaches
Volkov, G. L., Sp, H., Krasnobryzha, I. M., & Havryliuk, O. S. (2016) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-016-2209-2 · Cited by 4
Challenges and Risks of Nanotechnology in Medicine: An Immunologist's Point of View
Szebeni, J. (2016) · doi:10.1002/9783527692057.ch7 · Cited by 4
Engineering Glucose‐Responsive Insulin Granules with High‐Payload for Long‐Acting Glycemic Control
Chen, D.-Z., Yang, L., Ni, S., Jin, C., Xu, C., Zan, X.-J., Wang, Y., & Zhu, H. (2025) · Advances in Materials · doi:10.1002/adma.202501344 · Cited by 6
Polymer-Based Protein Delivery Systems for Loco-Regional Administration
Mansor, M. H., Garcion, E., Ramalapa, B., Buchtová, N., Toullec, C., Aucamp, M. E., Bideau, J. L., Hindré, F., Dube, A., Alvarez‐Lorenzo, C., et al. (2021) · CRC Press eBooks · doi:10.1201/9781003023197-17 · Cited by 3
Nanoparticle-Based Delivery Platforms for the Enhanced Oral Delivery of Peptides/Proteins
Salatin, S., Montazersaheb, S., Farjami, A., & Hamidi, S. (2023) · Therapeutic Delivery · doi:10.4155/tde-2023-0048 · Cited by 3
Antimicrobial activity of nanoemulsion containing Moringa oleifera seed protein
Nebolisa, N. M., Afuape, A. R., Aigbagenode, A. A., Onana, T. E., & Olaiyapo, O. F. (2024) · European Journal of Sustainable Development Research · doi:10.29333/ejosdr/15134 · Cited by 4
Wang, Y.-M., Ming, Y., Yu, Z., Xu, Z., Zou, M., Chen, C., Luo, F., Huang, D., Wang, N., Lin, Z., et al. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.4c01593 · Cited by 3
Yadav, B., Chahar, D., Kahlon, N. K., Weber, C. C., & Venkatesu, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146238 · Cited by 3
Nanoparticles hybridization to engineer biomaterials for drug delivery
Mohammadi, M. R., Sun, W., Inayathullah, M., & Rajadas, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100963-5.00008-2 · Cited by 3
Nanotechnology in Preclinical Pharmacokinetics
Malik, S., Ghosh, A., Kerry, R. G., & Rout, J. R. (2020) · Springer eBooks · doi:10.1007/978-981-15-2195-9_30 · Cited by 3
Hydrophobic interaction chromatography
Sarin, D., Joshi, S., & Rathore, A. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99968-7.00026-6 · Cited by 3
Innovation in Stabilization of Biopharmaceuticals
Prasad, S., & Roy, I. (2023) · Springer eBooks · doi:10.1007/978-981-99-2302-1_1 · Cited by 3
Sheikhi, M., Sharifzadeh, M., Hennink, W. E., Firoozpour, L., Hajimahmoodi, M., Khoshayand, M. R., & Shirangi, M. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.09.016 · Cited by 3
Roy, K., Mazumder, A., Ghosh, P., Naiya, G., Ghosh, B., & Roy, S. (2018) · Chemical Communications · doi:10.1039/c7cc09279b · Cited by 3
Emerging Peptide-Based Technologies in Cancer Therapy
Mallick, A. M., Chakraborty, K., Biswas, A., Jan, S., Dutta, C., Dey, S., Sahoo, S., Mandal, K., & Roy, R. S. (2019) · Springer eBooks · doi:10.1007/978-981-32-9816-3_2 · Cited by 3
Targeting Cancer Using Nanocarriers
Landesman‐Milo, D., Qassem, S., & Peer, D. (2016) · Advances in delivery science and technology · doi:10.1007/978-1-4939-3634-2_7 · Cited by 3
Formulation Strategies to Enable Delivery of Therapeutic Peptides across Cell Membranes
Doty, A. C., Jarvis, C. M., & Munsell, E. V. (2022) · ACS symposium series · doi:10.1021/bk-2022-1417.ch009 · Cited by 3
Volkov, G. L., Havryliuk, S. P., Krasnobryzha, I., & Havryliuk, O. S. (2017) · Journal of Biomolecular Research & Therapeutics · doi:10.4172/2167-7956.1000157 · Cited by 3
Chemical and Genetic Modification
Farys, M., Ginn, C., Badescu, G. O., Peciak, K., Pawlisz, E., Khalili, H., & Brocchini, S. (2013) · Wiley eBooks · doi:10.1002/9780470571224.pse508 · Cited by 3
Ismail, R. (2020) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10468 · Cited by 3
Cell‐Penetrating Peptides for Nucleic Acid Delivery – An Update
Vivès, É., Josse, E., Konate, K., Deshayes, S., & Boisguérin, P. (2022) · Wiley eBooks · doi:10.1002/9783527835997.ch14 · Cited by 3
Peptide Acylation in Aliphatic Polyesters: a Review of Mechanisms and Inhibition Strategies
Sheikhi, M., Nemayandeh, N., & Shirangi, M. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03682-6 · Cited by 2
Ryu, M.-C., & Choi, S. (2024) · ACS Macro Letters · doi:10.1021/acsmacrolett.4c00679 · Cited by 2
Therapeutic and Pharmaceutical Applications of PEGylated Nano-Carriers
Shakeri, R., Mirjalili, S. Z., Karakuş, C. Ö., & Safavi, M. (2025) · Springer eBooks · doi:10.1007/978-981-97-7316-9_18 · Cited by 3
Tuning Protein Uptake through Charge and Hydrophobicity in Peptide-Based Complex Coacervates
Sathyavageeswaran, A., Izzo, M., Sabadini, J. B., Habeeba, U., Belden, J., & Perry, S. L. (2026) · Biomacromolecules · doi:10.1021/acs.biomac.5c02639 · Cited by 2
Plowright, A. T., Engkvist, O., Gill, A. L., Knerr, L., & Wang, Q. (2014) · Angewandte Chemie · doi:10.1002/ange.201307034 · Cited by 2
Poly(lactic-co-glycolic acid) nanoparticle-mediated approaches for wound healing
Swain, S. S., Karri, V. V. S. R., Kuppusamy, G., Praveen, T. K., & Dutta, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22027-2.00018-x · Cited by 2
Beyond PEGylation “PEGylation and its Alternatives”
Mohanta, S., Muley, A., Upadhyay, M., Dahake, D., Tekade, M., Prasad, A. G., & Tekade, R. K. (2025) · Springer eBooks · doi:10.1007/978-981-97-7316-9_16 · Cited by 2
Bioengineered Saccharomyces cerevisiae with neprosin for gluten detoxification
Ting, T., Lee, W., Ramzi, A. B., & Goh, H. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2025.01.008 · Cited by 2
Wang, J., & Sheng-wu, H. (2014) · Chinese Herbal Medicines · doi:10.1016/s1674-6384(14)60002-2 · Cited by 2
Encapsulation of cationic peptides into polymersomes throughin situgelatinization
Gao, H., Pang, Z., Lü, W., Pan, S., & Jiang, X. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.578759 · Cited by 2
Basic Principles of Formulation for Biotherapeutics: Approaches to Alternative Drug Delivery
Otvos, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12415-1 · Cited by 2
Nanosized drug delivery systems as radiopharmaceuticals
Silindir‐Gunay, M., & Özer, A. Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46144-3.00022-2 · Cited by 3
Bioencapsulation for protein delivery
Mathew, G. M., Rajasekharan, R., Thomas, D., Binod, P., Pandey, A., & Sindhu, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91229-7.00012-x · Cited by 2
Polymer–protein conjugates as therapeutic
Hada, D., Simorgh, S., Singh, G. P., Chundawat, N. S., & Chauhan, N. P. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823797-7.00009-5 · Cited by 2
Gew, L. T., Suk, V. R. E., & Misran, M. (2018) · Current Chemical Biology · doi:10.2174/2212796812666180912113156 · Cited by 2
Half‐Life Extension with Pharmaceutical Formulations: Nanoparticles by the Miniemulsion Process
Landfester, K., Musyanovych, A., & Mailänder, V. (2012) · Wiley eBooks · doi:10.1002/9783527644827.ch17 · Cited by 2
PEGylation strategy to the development of analytical and therapeutic proteins
Santos, J. M. (2019) · doi:10.11606/t.9.2019.tde-23092019-124950 · Cited by 2
Enzyme responsive delivery of engineered antibody fragments
Zhong, L. (2023) · doi:10.3990/1.9789036559706 · Cited by 2
Unraveling the Biofilm Matrix for Targeted Treatment Strategies
Flom, T., Nair, G., Nicolo, I., Fleming, D. F., & Redman, W. K. (2024) · Springer series on biofilms · doi:10.1007/978-3-031-70476-5_9 · Cited by 2
Sofi, H. S., Lora, A. J., Aggarwal, S., Infanger, D. W., Lawrence, B. D., & Mansour, H. M. (2025) · ACS Omega · doi:10.1021/acsomega.4c08514 · Cited by 1
Zhang, C., Yang, A., Lin, H., Li, Z., & Lü, W. (2026) · Journal of Functional Biomaterials · doi:10.3390/jfb17020094 · Cited by 1
Certolizumab pegol therapy of rheumatoid arthritis: Overview
Zidi, I., Mnif, W., Bouaziz, A., & Amor, N. B. (2011) · Drug Development Research · doi:10.1002/ddr.20470 · Cited by 1
Bobone, S. (2014) · Springer theses · doi:10.1007/978-3-319-06434-5_5 · Cited by 1
Introduction to Protein Therapeutics
Jain, M., Kumar, A., Khan, R. J., Jha, R. K., Singh, E., Muthukumaran, J., & Singh, A. K. (2023) · Springer eBooks · doi:10.1007/978-981-19-8249-1_1 · Cited by 1
Advanced Targeting Systems for Tissue-Specific Drug Delivery
Nastasi, C. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_292 · Cited by 2
Biopharmaceutical Manufacturing
Barwant, M. M., Singh, B., & Vazirizadeh, A. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-2873-7.ch010 · Cited by 1
Micro- and Nanoscale Delivery of Therapeutic Agents for Regenerative Therapy
Saul, J. M., & Harrison, B. S. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139047357.009 · Cited by 1
Biophysical Characterization of Polysialic Acid—Membrane Nanosystems
Sapoń, K., Janas, T., & Janas, T. (2019) · Series in bioengineering · doi:10.1007/978-981-13-0989-2_11 · Cited by 1
PEGylated DPPC/Anti-SNAP25 Antibody Targeted Liposomes from Langmuir Monolayer Study to Formulations
Gew, L. T., & Misran, M. (2021) · Current Chemical Biology · doi:10.2174/2212796815666210804111958 · Cited by 1
CNT-Based Nano Medicine From Synthesis to Therapeutic Application
Ansari, S. Y., Ansari, S. A., Alshammari, F. F., & Anwar, S. (2021) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-7998-8251-0.ch006 · Cited by 1
Chen, X., Liu, T., Yuan, P., Chang, X., Yin, Q., Mu, W., & Peng, Z. (2023) · Micro/Nano technologies · doi:10.1007/978-981-16-8984-0_11 · Cited by 1
An Investigation into the World of Protein-Based Therapeutics-Therapeutic Proteins
Ashwin Prabahar, A. (2023) · Journal of Clinical and Medical Research · doi:10.37191/mapsci-2582-4333-5(3)-135 · Cited by 1
Pine pollen for molecular encapsulation and oral delivery applications
Prabhakar, A. K. (2018) · doi:10.32657/10356/75839 · Cited by 1
Controlled delivery of macromolecules and peptides
Lee, D., & Khang, G. (2013) · doi:10.4155/ebo.13.19 · Cited by 1
Blanco‐Prieto, M. J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.001 · Cited by 1
Transfection of functional proteins with DNA-protein nanogels-lipids complexPreprint
Mariconti, M., Escriou, V., Morel, M., Baigl, D., Hoffmann, C., & Rudiuk, S. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-5455b · Cited by 1
Controlling protein release using biodegradable microparticles
Kline, B. P. (2014) · Purdue e-Pubs (Purdue University System)
Continuous Membrane Bioreactor (CMBR) to Produce Nanoparticles from Milk Components
Nieto-Nieto, V., Amaya‐Llano, S. L., & Ozimek, L. (2012) · InTech eBooks · doi:10.5772/38888
Vision'ary: drug delivery for ocular diseases
Sarver, A. J. (2015) · Huskie Commons (Northern Illinois University)
Brain as a Sancturian Site in Drug Delivery Approaches to Improve Bioavailability in Brain
Sonawane, S. (2014) · Pharmatutor
Jørgensen, L., Groenning, M., Roest, N., Pinholt, C., & van de Weert, M. (2013) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(13)50051-7
Keefe, A. J. (2013) · ResearchWorks at the University of Washington (University of Washington)
Molecular approaches to chemotherapeutic targeting
Wager, K. (2012) · doi:10.17760/d20002666
Low melting point and amphiphilic polymer microspheres for therapeutic protein delivery
Louka, D. (2015) · QSpace (Queen's University Library)
Wang, L. (2015) · OhioLink ETD Center (Ohio Library and Information Network)
Novel strategy to inhibit the oncogenic transcription factor c-Myc in triple-negative breast cancer
Mejzini, R. (2016) · Murdoch University Research Portal
Mariani, A. M., & Sapsford, K. E. (2017) · doi:10.1002/9783527683451.ch9
Biodegradable Polymers for Protein and Peptide Therapeutics: Next Generation Delivery Systems
Dyawanapelly, S., Jain, N. K., Kr., S., Prasanna, M., & Singh, A. V. (2017) · Handbook of Composites from Renewable Materials · doi:10.1002/9781119441632.ch18
Developments and Diversity of Proteins and Enzymes
Srivastava, A., Bansal, S., & Shankar, J. (2017) · Springer eBooks · doi:10.1007/978-981-10-5511-9_2
Nanoparticle-mediated Cell Behavior Modulation for the Treatment of Myocardial Infarction
한진 (2017) · Seoul National University Open Repository (Seoul National University)
Oat protein structure-function properties and value-added application
Nieto, N. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3t727m9s
Crasto, G. J. (2016) · TSpace (University of Toronto)
Bioresponsive Drug Delivery by Microneedle Patches.
Zhang, Y. (2018) · NCSU Libraries Repository (North Carolina State University Libraries)
Conjugates, Polymer–Drug: Polymer–Protein Drug Delivery
Kaur, H., Singh, J., & Kumar, R. (2016) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120050043
Biodegradable Polymers: Protein Therapeutics Delivery
Vaidya, B., & Vaidya, S. (2016) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120049274
Metadata
- Authors
- Pisal, D. S., Kosloski, M. P., & Balu-Iyer, S. V.
- Affiliations
- University at Buffalo, State University of New York (US)
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 99
- Issue
- 6
- Pages
- 2557-2575
- ISSN
- 0022-3549 (ISSN-L)
- PMC
- PMC2857543
- OpenAlex
- W1985516113
- Cited by
- 532
- References
- 160
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 14 · 2023: 38 · 2022: 25 · 2021: 31 · 2020: 42 · 2019: 44 · 2018: 45 · 2017: 43 · 2016: 48 · 2015: 40 · 2014: 48 · 2013: 26 · 2012: 28
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Pfizer
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL070227, HL-70227)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- therapeutic proteins, drug delivery, protein stability, immunogenicity, protein half-life, PEGylation, polysialic acid, glycolic acid, nanoparticle drug delivery, liposomes, polymeric nanoparticles, polymer microspheres, colloidal drug delivery
- MeSH terms
- Chemistry, Pharmaceutical, Half-Life, Humans, Liposomes, Microspheres, Polyethylene Glycols, Polymers, Proteins, Sialic Acids, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review